Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin Activity, Aldosterone, Cortisol, and Catecholamines
Hypertension, 10/12/09
Snoep JD et al. – Aspirin taken at bedtime compared with on awakening significantly diminished 24–hour plasma renin activity and excretion of cortisol, dopamine, and norepinephrine in 24–hour urine. Decreased activity of these pressor systems forms a biologically plausible explanation for the finding that aspirin at night may reduce blood pressure, whereas aspirin at morning does not.
Jaapjan D. Snoep, 10/13/09
| Aspirin is generally not believed to influence blood pressure. However, several recent studies have suggested that aspirin, when taken at bedtime, reduces blood pressure, whereas aspirin intake in the morning does not affect blood pressure. Until now, a biologically plausible mechanism underlying this striking difference according to time of intake has not been provided. In a randomized crossover trial, we have found that aspirin at bedtime compared to on awakening reduces plasma renin activivity over 24h as well as cortisol and catecholamines in 24h urine. Time-dependent decreased activity of these pressor systems can explain the found differential effects of aspirin on blood pressure according to time of intake. |
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension
Journal of Human Hypertension, 11/10/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09
Article Search
Sponsor


See Latest Articles


